Overview
Anil Bargale practices practicing medicine in Dharwad, India.
His clinical expertise encompasses Preeclampsia, Thrush, Pyoderma Gangrenosum, and Triple-Negative Breast Cancer.
He is actively involved in clinical research, co-authoring 15 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Anil B. Bargale
Is Anil B. Bargale a top-rated expert for Preeclampsia?
MediFind is an objective health platform that identifies experts based on real-world data. Anil B. Bargale is classified as an Experienced expert for Preeclampsia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Anil B. Bargale participate in research or clinical trials?
Yes. Anil B. Bargale has published 15 articles and abstracts on conditions like Preeclampsia. You can view a list of Anil B. Bargale's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- PreeclampsiaMr. Bargale isExperienced. Learn about Preeclampsia.
- Pyoderma GangrenosumMr. Bargale isExperienced. Learn about Pyoderma Gangrenosum.
- ThrushMr. Bargale isExperienced. Learn about Thrush.
- Triple-Negative Breast CancerMr. Bargale isExperienced. Learn about Triple-Negative Breast Cancer.